Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

NCT02955706 ·Status: COMPLETED ·Phase: PHASE4

Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.

NCT04552041 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of MMFS in Early AD

NCT03531684 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

NCT06850597 ·Status: RECRUITING ·Phase: PHASE2

Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease

NCT04346862 ·Status: UNKNOWN ·Phase: PHASE4

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

NCT06336174 ·Status: RECRUITING

DMB-I in the Treatment of Alzheimer Type Dementia

NCT06292351 ·Status: COMPLETED ·Phase: PHASE2

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

NCT02788513 ·Status: COMPLETED ·Phase: PHASE2

A Study of NH280105 in Healthy Adult Participants

NCT06870058 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults

NCT02181972 ·Status: COMPLETED ·Phase: PHASE3

Local Study of Akatinol Memantine in VaD in Russia

NCT03986424 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

NCT00200538 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

NCT00947531 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

NCT02149160 ·Status: UNKNOWN ·Phase: PHASE2

Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment

NCT00530478 ·Status: UNKNOWN ·Phase: NA

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease

NCT02880956 ·Status: COMPLETED ·Phase: PHASE2

3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease

NCT01374438 ·Status: COMPLETED ·Phase: PHASE2

A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

NCT05466422 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00105547 ·Status: COMPLETED ·Phase: PHASE3

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

NCT00035191 ·Status: COMPLETED ·Phase: PHASE3

Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

NCT02423200 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 ·Status: COMPLETED ·Phase: PHASE2

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

NCT03703856 ·Status: COMPLETED ·Phase: PHASE4

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

NCT00930059 ·Status: COMPLETED ·Phase: PHASE2